Search Constraints
Search Results
Select an image to start the slideshow
COVID-19 Mitigation Strategies: Implications for Pandemic Control and the Incidence of Drug-Resistant Tuberculosis
1 of 10
Estimating the changing prevalence of tuberculosis infection in the United States, 1971-2015
2 of 10
Transmission patterns of extensively drug-resistant tuberculosis in South Africa: a network approach
3 of 10
High Latent Tuberculosis Infection Test Conversion Rates among
Healthcare Workers in the Country of Georgia
4 of 10
Approval Sheet Risk Factors for Poor Treatment Outcomes
among Patients with Multi-Drug Resistant and Extensively
Drug-Resistant (M/XDR) Tuberculosis in the Country of Georgia.
5 of 10
The role of the granuloma in bacterial expansion anddissemination during early tuberculosis
6 of 10
Development of Monocarbonyl Curcumin Analogues Towards Treating
Tuberculosis and Cancer
7 of 10
Interferon Gamma Release Assay Result is Associated with Site of
Disease and Death in Active Tuberculosis
8 of 10
Diagnosis of Latent Tuberculosis Infection among HIV discordant
partners using Interferon-Gamma Release Assays (IGRAs).
9 of 10
Modulation of innate-adaptive immune crosstalk during Mycobacterium tuberculosis infection
10 of 10